血管炎(Vasculitis)：世界の治験レビュー（2015年上半期版）...市場調査レポートについてご紹介

Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Introduction 6
Vasculitis 6
Report Guidance 6
Clinical Trials by Region 7
Clinical Trials and Average Enrollment by Country 8
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10
Top Five Countries Contributing to Clinical Trials in Europe 11
Top Countries Contributing to Clinical Trials in North America 12
Top Countries Contributing to Clinical Trials in Middle East and Africa 13
Top Countries Contributing to Clinical Trials in Central and South America 14
Clinical Trials by G7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials 15
Clinical Trials by Phase in G7 Countries 16
Clinical Trials in G7 Countries by Trial Status 17
Clinical Trials by E7 Countries: Proportion of Vasculitis to Cardiovascular Clinical Trials 18
Clinical Trials by Phase in E7 Countries 19
Clinical Trials in E7 Countries by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Clinical Trials by End Point Status 24
Unaccomplished Trials of Vasculitis 25
Subjects Recruited Over a Period of Time 28
Clinical Trials by Sponsor Type 29
Prominent Sponsors 30
Top Companies Participating in Vasculitis Therapeutics Clinical Trials 31
Prominent Drugs 33
Latest Clinical Trials News on Vasculitis 34
Apr 21, 2015: Kineta, University of Groningen Present New, Positive Data for Dalazatide in ANCA Vasculitis, an Orphan Disease 34
Clinical Trial Profiles 35
Clinical Trial Overview of Top Companies 35
F. Hoffmann-La Roche Ltd. 35
Clinical Trial Overview of F. Hoffmann-La Roche Ltd. 35
Novartis AG 37
Clinical Trial Overview of Novartis AG 37
Zenyaku Kogyo Co., Ltd. 38
Clinical Trial Overview of Zenyaku Kogyo Co., Ltd. 38
Pluristem Therapeutics Inc. 39
Clinical Trial Overview of Pluristem Therapeutics Inc. 39
GlaxoSmithKline plc 40
Clinical Trial Overview of GlaxoSmithKline plc 40
ChemoCentryx, Inc. 41
Clinical Trial Overview of ChemoCentryx, Inc. 41
AnGes MG, Inc. 42
Clinical Trial Overview of AnGes MG, Inc. 42
Actelion Ltd 43
Clinical Trial Overview of Actelion Ltd 43
AbbVie Inc. 44
Clinical Trial Overview of AbbVie Inc. 44
Clinical Trial Overview of Top Institutes / Government 45
Assistance Publique – Hopitaux de Paris 45
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 45
The National Institute of Allergy and Infectious Diseases 46
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 46
Cambridge University Hospitals NHS Foundation Trust 47
Clinical Trial Overview of Cambridge University Hospitals NHS Foundation Trust 47
Saitama Medical University 48
Clinical Trial Overview of Saitama Medical University 48
Ministry of Health, Labour and Welfare, Japan 49
Clinical Trial Overview of Ministry of Health, Labour and Welfare, Japan 49
Nanjing University 50
Clinical Trial Overview of Nanjing University 50
Osaka University 51
Clinical Trial Overview of Osaka University 51
Pitie-Salpetriere Hospital 52
Clinical Trial Overview of Pitie-Salpetriere Hospital 52
University Hospital, Toulouse 53
Clinical Trial Overview of University Hospital, Toulouse 53
University Medical Center Groningen 54
Clinical Trial Overview of University Medical Center Groningen 54
Five Key Clinical Profiles 55
Appendix 79
Abbreviations 79
Definitions 79
Research Methodology 80
Secondary Research 80
About GlobalData 81
Contact Us 81
Disclaimer 81
Source 81